ロード中...
Gene mutation and surgical technique: suggestion or more?
Advancements in chemotherapy and molecular targeted therapy have improved long-term outcomes for patients with resectable colorectal liver metastases (CLM). RAS mutation status was an original focus as a molecular biomarker as it predicted treatments response to anti-epidermal growth factor receptor...
保存先:
| 出版年: | Surg Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6980434/ https://ncbi.nlm.nih.gov/pubmed/31351766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2019.07.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|